알닐람 제약 주식 심층 분석: 애널리스트 24명의 시각

지난 3개월간 24명의 애널리스트가 알닐람 제약(나스닥: ALNY)에 대한 평가를 내놓았다. 이들의 견해는 강력 매수에서 약세까지 다양하게 나타났다.아래 표는 최근 30일간의 평가와 이전 달들의 평가를 비교해 보여준다.강력 매수매수중립매도강력 매도총 평가138300최근 30일100001개월 전861002개월 전011003개월 전41100애널리스트들이 제시한 12개월 목표주가를 살펴보면 평균 322.83달러, 최고 400달러, 최저 220달러로 나타났다. 현재 평균 목표주가는 이전의 306.57달러에서 5.3% 상승했다.애널리스트 평가 해석: 종합 분석알닐람 제약에 대한 금융 전문가들의 인식을 명확히 파악하기 위해 최근 애널리스트들의 행동을 철저히 분석했다. 아래 요약은 주요 애널리스트들의 최근 평가와 등급 및 목표가 조정 내용을 설명한다.애널리스트소속조치등급현재 목표가이전 목표가패트릭 트루치오(Patrick Trucchio)HC 웨인라이트(HC Wainwright & Co.)유지매수..................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................